Sector Watch: Healthcare - May 14 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $107.68 +1.10 1.03% | XBI: $92.82 +1.17 1.28% | Updated May 14, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| PRPH52WH ProPhase Labs $57.1M |
5.21+1.10 205.4 K 7.2x |
27% | ||
| TNDM Tandem Diabetes Care $498.2M |
11.15+2.25 7.4 M 3.6x |
25% | ||
| BDSI BioDelivery Sciences International $123.4M |
2.05+0.35 818.0 K 3.2x |
21% | ||
| GALT Galectin Therapeutics $148.0M |
4.00+0.64 3.8 M 9.1x |
19% | ||
| AST Asterias Biotherapeutics $79.4M |
1.70+0.25 787.0 K 5.0x |
17% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| NWBO Northwest Biotherapeutics $87.5M |
0.21-0.02 1.7 M |
-9% | ||
| PFNX Pfenex $130.1M |
6.10-0.55 106.8 K |
-8% | ||
| JNP Juniper Pharmaceuticals $98.5M |
8.70-0.75 80.0 K |
-8% | ||
| MNLO Menlo Therapeutics $209.7M |
9.53-0.61 163.1 K |
-6% | ||
| AGEN Agenus $328.1M |
3.35-0.21 3.4 M 2.5x |
-6% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for Submission of New Drug Application in Third Quarter 2018 [prnewswire.com]Galectin Therapeutics Proceeds to Phase 3 Development of GR-MD-02 for NASH Cirrhosis Following FDA Meeting [globenewswire.com]
Galectin Therapeutics Reports 2018 First Quarter Financial Results and Provides Business Update [globenewswire.com]
BioTime Reports First Quarter Results and Recent Corporate Accomplishments | Business Wire [businesswire.com]
BioDelivery Sciences Reports Positive First Quarter 2018 Financial Results and Provides Corporate Update [globenewswire.com]
Tandem Diabetes Care to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference | Business Wire [businesswire.com]
Menlo Therapeutics Reports First Quarter 2018 Financial Results [globenewswire.com]
Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018 - ResearchAndMarkets.com | Business Wire [businesswire.com]
Portal Hypertension Drug Development Pipeline Study, H1 2018 - ResearchAndMarkets.com | Business Wire [businesswire.com]
2018 Liver Cirrhosis Drug Development - Pipeline Analysis Report - ResearchAndMarkets.com | Business Wire [businesswire.com]
PROPHASE LABS, INC. ANNOUNCES SPECIAL CASH DIVIDEND [globenewswire.com]
Agenus to Present at Deutsche Bank?s 43rd Annual Health Care Conference in Boston [prnewswire.com]
Agenus to Present at Deutsche Bank's 43rd Annual Health Care Conference in Boston [prnewswire.com]
Menlo Therapeutics Announces Senior Clinical Leadership Updates [globenewswire.com]
BioDelivery Sciences Appoints Herm Cukier as Chief Executive Officer [globenewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
